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With advances in genomic discovery tools, recent biomedical research has produced a massive amount of genomic data on post-transcriptional regulations
related to various transcript factors, microRNAs, lncRNAs, epigenetic modifications, and genetic variations. In this direction, the field of gene regulation
network inference is created and aims to understand the interactome regulations between these molecules (e.g., gene-gene, miRNA-gene) that take place
to build models able to capture behavioral changes in biological systems. A
question of interest arises in integrating such molecules to build a network
while treating each specie in its uniqueness. Given the dynamic changes of
interactome in chaotic systems (e.g., cancers) and the dramatic growth of heterogeneous data on this topic, building scalable models is crucial. Indeed,
recovering a model that can capture the relationships within this data constitutes a major challenge. This thesis addresses this challenge by using an
integrative network learning model based on gene expression data to elucidate
miRNA – gene interactions in cancer progression. First, we present a preprocessing pipeline for miRNA-gene interactions based on De Novo approach.
Second, we introduce a machine learning approach for data integration of
multiple data types such microarray, RNA-seq and CLIP based miRNA-RNA

interactions along with graphical model fusion. Last, we show how the latter enabled transforming static interactions into semi-conditional ones. In a
case study of human pancreatic cancer, we have identified gene regulatory
networks distinctly associated with four progressive stages with a list of 12
miRNA-gene conditional interactions; The functional analysis with focus on
microRNA-mediated dysregulation revealed significant changes in major cancer hallmarks. The identified novel pathological signaling and metabolic processes shed light on the regulatory roles that microRNAs play in pancreatic
cancer progression. We believe this integrative model can be a robust and
effective discovery tool to further the understanding of key regulatory characteristics in complex biological systems.
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Chapter 1

Introduction

1.1

Overview

In the post-genomic era in which we are, one of the challenging task for researchers is how to decipher genes regulations. Gene regulation presents a
set of mechanisms used by cell to control gene expressions’ products, these
products are RNA or proteins. Understanding of such regulations enables discovery of new drug targets for disease treatment, which remains challenging as
the dynamic nature of miRNA interactions, as well as the evolving functions,
are largely undetermined. However determining those interactions under the
context of a multi-layer regulation network leads to challenges in information
fusion and network fusion. Information fusion, which refers to an effective integration of heterogeneous data analyses that reflect distinct regulatory mechanisms. For example, each type of high-throughput data such as microarray
or RNA-seq based expression profiles, CLIP or CLASH based miRNA-RNA
interactions, and ChIP-seq TF binding profiles, as well as methylation and
genetic profiles from DNA sequencing analysis can be used to infer a certain
type of molecular interaction. Molecular interactions such as microRNA-gene
regulations are important to understand the pathological mechanism of human
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cancers. Network fusion, the second identified challenge lies in the integration
of heterogeneous interaction networks inferred from different models without
losing proper causality inference among the interactions.

1.2

Motivation

In system biology, GRN reconstruction is of great interest as it enables the
discovery of genetic mechanisms driving diverse diseases, such as cancer [51].
These mechanisms are defined by interactions among molecules that made
up the organism. Hence, relationships between such molecules can be summarized as a network, where nodes are molecules and the links between the
nodes are interactions of interest. Several network models have been built that
captured biology interactions of genes, but very few have succeeded to capture
miRNA-gene interactions in an integrative way. Many of the conventional
methods used in genomic data analysis do not take advantage of the interactions between multiple factors, as in the case of miRNA and mRNA they
regulate, failing thereby to uncover the cellular processes that are unique to
specific tissues [29]. We have identified two major challenges, information fusion and network fusion. First, to address the information fusion challenge, we
explored the De Novo approach for miRNA-gene interactions based on CLIP
data and graphical lasso network method for building network from microarray
and RNA-seq based expression profiles data. Effective information fusion can
transform a static interaction analysis into a semi-conditional manner, leading to more practically useful results. Secondly, to tackle the network fusion
challenge, we proposed a more generalized Bayesian Network framework for
model integration while keeping the proper causality. The models used so far
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to predict miRNA-gene interactions have proven to be limited. A network that
capture gene-gene or miRNA-gene interactions based on a unique data source
will not provide the full mechanism that underlies miRNA-gene interactions
for a given tissue or specific disease. Those limitations vary from the unsupervised nature of the model to the model’s assumptions that do not always hold
[56]. With this in mind, it is crucial to develop computational model that will
exploit the full potential of high-throughput data to discover the full potential
of miRNA impact on cancer associated genes regulation. GRN is generally
represented as a graph where the nodes are the genes and the edges their
interactions. This graph’s edges can be directed or undirected. A directed
graph will provide causality in the network, hence the GRN inference. Our
problem is how to capture these causality in a meaningful way, how to find the
true causal links in the network, without biased (without limiting the types of
available interactions i.e., gene-gene, miRNA-gene) based on the participating
genes. Individual interactions do not provide a full picture of these biological
entities (this has as consequence more false positive than true positive) where
the need to explore additional interactions, specifically gene-gene interactions,
will expands the benefits of a GRN with regards to functional analysis.

1.3

Contribution

The aim of the study is then to design a more generalized network framework
for model integration while keeping the proper causality which will identify
with high confidence a set of miRNA-gene interactions through an information fusion scheme that will infer regulatory mechanism underlying cancer
progression. Knowledge of the functional miRNAs-gene interactions can help
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find the driving factor (source or reason) of a genetic disease, which can provide more insights to biologist and researchers in their quest for targeted and
efficient care and treatment. Taking advantage of the prior knowledge, we
proposed a graphical model using Bayesian Network to predict interactions
between miRNA-gene and then using those to update the GRN and discover
more true causal structures. To demonstrate the proposed techniques, Pancreatic cancer will be used as case study where miRNA-gene will hep uncover
cancer progression and functional analysis.

1.4

Thesis outline

The next chapter provides the background required for network reconstruction
and related works using Regression, Bayesian and deep learning methods in
gene network reconstruction. Chapter 3 describes the cancer data used in this
study and provides an exploratory data analysis. Detailed explanation of the
datasets is provided along with the preprocessing techniques we use to narrow
down the number of genes and to identify the interactions of interest. Chapter
4 introduces a De Novo approach to identify miRNA-gene interactions and a
Bayesian framework for GRN reconstruction along with a binding network for
network fusion. Chapter 5 presents and discuss the results. Finally, Chapter
6 presents the conclusion and future of this thesis.
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Chapter 2

Background and Related Work

2.1
2.1.1

Background
Genes and microRNA

Genes are regions of DNA that encodes functional RNAs or proteins and they
are the molecular units of heredity. RNA molecule folds into a “unique” tertiary structure to carry a particular set of biochemical functions. The Human
Genome Project estimated that humans have about 21,000 genes. Messenger
RNA (mRNA) is copy of RNA obtained after transcription. mRNA is a singlestranded RNA molecule of RNA that is complementary to one of the DNA
strands of a gene and is read by a ribosome in the process of synthesizing a
protein. Changes in mRNA expression are key in cancer onset and progression.
Whereas MicroRNAs are a class of single-stranded endogenous non-coding
RNAs that are about 19 to 25 nucleotides (nt) in length [6]. They are used by
cell to control gene expression mainly by binding with mRNA. One miRNA
can simultaneously bind to various target mRNAs, long non-coding RNAs, and
circular RNAs and meanwhile, one gene can be regulated by multiple miRNAs.
MicroRNAs do not bind to mRNAs on their own but rather function as a component of the RNA-induced silencing complexes (RISCs). Mature miRNAs are
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mostly known to repress gene expression at post-transcriptional levels by binding to the 30 untranslated region (UTR) of the target mRNA transcripts [6].
There are evidences that miRNA expression is dysregulated in cancer through
various mechanisms, including amplification or deletion of miRNA genes, abnormal transcriptional control of miRNAs, dysregulated epigenetic changes
and defects in the miRNA biogenesis machinery. miRNAs influence numerous
cancer-related cellular processes such as cell proliferation, cell cycle control,
apoptosis and metabolism [13] via its own dysregulation. Their dysregulation
confer malignant cells their tumorigenic potential. Understanding the impact
of such regulation is of highest importance but miRNA interactions and functions are still largely unknown. A miRNA can regulate one to many genes
while several miRNA can target and regulate the same gene.

2.1.2

Gene regulation networks (GRNs)

Gene regulation network is a directed graph representing all the molecules interacting jointly to control genes expression. It is made up of regulators such
Transcription factors (TFs), microRNA (miRNA) which bind to the promotor regions of their target genes and act on them as activators or inhibitors.
These directed edges of the GRN enable clear identification of regulators and
regulated nodes which explain the direction of causality in the network. Reconstruction and understanding of such network, GRN, has great potential in
understanding diseases initiation and progression. Reconstructing GRN therefore is required to understand how gene expression dysregulation contributes
to cancer and other complex heritable diseases [5].

7

2.2

Literature review on network inference

Many algorithms have been developed to infer the GRNs from unsupervised
to supervised methods, from model-based to probabilistic methods. Here we
present regression based, probabilistic-Bayesian Network and deep learning
approaches. Note that not all of these studies that will follow are directly
related to miRNA-gene interaction. However, the proposed methods are in
line with the approaches under scrutiny in this study.

2.2.1

Data fusion and integration

In the high-throughput biomolecular data context, data integration is typically performed in four different manners. One is to analyze each data type
separately first and then integrate the final findings. Another manner is to preprocess each type of data independently, then perform cross-platform normalization across the data types, then combine the normalized figures and finally
perform an overall analysis. The third type of integration consists of performing a statistical integration. The fourth approach is to integrate the data by
modeling the data types based on the biological meaning of the molecules and
their interactions [21] As reported in [21, 50], data integration is done in vertical and horizontal direction. In this work, we will follow the vertical direction,
ie the vertical multi-omics analysis which is performed within the cohort as opposed to horizontal, out of scope, which is a cross-cohort data integration. In
line with data integration, Glass et al. proposed PANDA [16] an integrative
method based on information sharing between different data sources by aggregating such information to build a coherent regulatory network. Their method
is based on similarity. They defined the notion of agreement and availability
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which enable reconstruction of genome-wide, condition-specific regulatory networks by weighing and integrating such data in a manner which first checks
the availability of a target gene to be regulated by a TF against its likely the
responsibility a TF is measured to have in regulating that gene.

2.2.2

Probabilistic methods

Bayesian based methods [34] when dealing with small sample size, Bayesian
networks are preferred as they proved to be less influenced by biological noise,
BN is based on probability theory. They proved to be make accurate prediction in face incomplete data. BN is one of the first established methods for
integrating prior knowledge which encodes biological information as a prior
distribution over graph structures [24] (Imoto et al., 2003). Using a heuristic greedy optimization, both the hyperparameters and network structure are
inferred by maximizing the joint posterior distribution. This framework has
been applied to a wide variety of priors in conjunction with gene expression
data.

2.2.3

Machine and deep learning based methods

Lyu et al. [39] in their work on tumor type classification using GE data, presented a DL approach that used Convolutional Neural Networks (CNN) at its
core. They proposed an embedding of high dimensional RNA-seq data into a
2-D image. To learn tumor-specific gene, they combined a large set of genes
from various tumors from the PANCAN for training the model, using this
knowledge from multiple tumor types they were able identified tumor-specific
gene. They achieved an accuracy of more than 95% on the PANCAN datasets.
One major take-away in their work was the the image embedding which tackled
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perfectly the challenges imposed by high dimensional genomic data. Yuan et
al. [56] also offered an embedding of GE into 2-D image following a NEPDF as
input to a CNN model. Their CNN allowed concatenation of additional data
type at FC layer. In [40] the authors proposed 3 different implementations
of their CNN models based on 1D (vector input), 2D (matrix input) and 2D
and again high accuracy was achieved here as well (93-95%). The authors
took a completely novel/different approach on their CNN architecture by implementing only 1 convolution layer, suggesting shallower models suitable for
cancer type prediction as such models help addressed the curse of dimensionality problem. CNNC offered a Deep Learning approach where expression
data are transformed in an image-like input and fed into a CNN architecture
to learn interaction between pair of gene.

2.2.4

Regression based methods

Another important category of GRN inference methods is based on regression
methods, which are used to predict one target gene based on one or more input
genes. These methods are amongst the most popular and scalable approaches
for reconstructing directed networks [23]. Regression based methods enable
learning high-order conditional dependencies between genes expressions. TargetScan [2] based on multiple linear regression, predicts biological targets of
miRNAs by focusing on canonical binding sites within 3 -UTR regions and performs species-specific prediction. It uses stepwise variable selection based on
Akaike information criterion. Lu et al. [38] proposed a Lasso regression based
on Targetscan [2] for target prediction, and their proposed method offered reliable miRNA-mrna interactions based on combined sequence-based prediction,
co-regulation and RISC availability and expression data. Another example of
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method using linear regression is TIGRESS [19], GRN inference is formulated
as a sparse linear regression problem where regulators of each target gene are
learned by combining feature selection with least-angle regression with stability selection [48]. Jacobsen et al. [25] use multivariate linear regression model
in miRNA-mRNA association to account and deal with noise introduced as a
result of gene alterations. miRanda [7] on the other hand uses support vector
regression and assesses the thermodynamic folding energy mirna:utr duplex.

2.3

Graph theory basics for GRN

Graph theory is the branch of mathematics that studies graphs, and networks
are often referred to as graphs. In this section we will present a brief review of
the most important terminologies needed to understand GRN. Mathematically
speaking a graph, network, is an ordered pair G = (V, E) where V is a finite
set of vertices or nodes and E a set edges. Edges in a graph are said to be
adjacent if they have a common node, in the same way vertices are said to be
adjacent if they shared common edges. A particular vertex can be connected
with more than one vertex, the number of edges that end (or start) at this
particular edge is called the degree of the vertex. One major property of graph
network, essential in GRN is the degree distribution. First, the degree of a
node is defined as the number of edges it has with other nodes. In the case of
a causal relationship i.e. a directed graph therefore we identify two types of
node’s degree: the in-degree (number of incoming edges) and the out-degree
(the number of outgoing edges). Knowing the degree of each nodes give the
degree distribution, which is defined as the probability of these degrees across
all nodes in the network, denoted Pdeg(k) . It is the fraction of nodes in the
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graph with in-degree and out-degree. This property, the degree distribution of
a graph enables us to learn network’s structure (such as the presence of hubs)
and to have a clear distinction between the types of network. It decays as a
power law for many real networks [5], which is the defining property of scalefree networks. A scale-free network is a signature for a GRN. The topology of
scale-free networks is dominated by a few highly connected nodes (hubs) which
link the rest of the less connected nodes to the system. This property gives the
network a great tolerance against errors, the nodes are able to communicate
even with very high failure rates.

2.4

GRN performance evaluation

Several prediction programs and algorithms exist to predict miRNA-target
interactions. Since they do not have the same approaches and use different
principles in their implementations, they can not get the exact same results
and conclusions. For example, one program will predict a miRNA-target interaction to be functional whereas a second program will conclude that this
same interaction is not. Hence, how can the inferred network be assessed?
Networks are compared by means of their edges, presence or absence of edge
in both network: inferred and actual regulatory network. GRN inference can
therefore be classified as a binary classification problem, i.e. each inferred interaction will either be classified as true or not, and it can be actually true
or not. From those inferred interactions we can derive a confusion matrix.
As opposed to standard interpretation, the meaning of the confusion matrix’s
metrics (TP, TN, FP and FN) are as follow:
• TP: True Positive is the number of predicted miRNA-target interactions
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that do actually exist. These are are edges occurring in the reconstructed
network, and that also occur in the gold standard network.
• TN:True Negative refer to edges that neither belong to the inferred network nor the actual network.
• FP: False Positive is the number of miRNA-target interactions occurring
in the inferred network, but that do not appear in the actual network.
• FN: False Negative is the number of miRNA-target interactions that
exist in the actual network but missing in the predicted network.
From these metrics, we can derive three statistical metrics essential in assessing
GRN performance and these are:
• Precision is the proportion of interactions predicted as positives that are
actual positives.

P recision =

TP
T P +F P

(2.1)

• Sensitiviy, Recall or True Positive Rate (TPR): the proportion of actual
positive interactions found

Sensitivity =

TP
T P +F N

(2.2)

• Specificity, which can be seen as the ratio between the correctly nonpredicted interactions and the number of total non-existing interactions
(correctly non-predicted and incorrectly predicted). Thus defined as:

Specif icity =

TN
T N +F P

(2.3)
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With the above statistical metrics, we can graphically explore the trade-off
between these metrics and derive two important curves: AUPRC and AUROC.
AUPRC, the area under the Precision-Recall curve plots the P recision against
the Recall. This measure is more suitable for imbalanced classes such in cancer
data and it is commonly used in GRN inference. AUROC, on the other side
display Sensitivity as a function of 1 − Specif icity also called False Positive
Rate. The above described metrics and measurements will be used in the this
study for performances analysis.

14

Chapter 3

Genomics Data on Pancreatic Cancer

In this chapter, data sources and data preprocessing is explored and data exploratory analysis is performed with outputs needed for downstream analysis.
Figure 3.1 presents the workflow of the data preprocessing. In line with one
of the challenges reported in this study, effective information fusion.

Figure 3.1: Workflow for miRNA-gene interaction data preprocessing

3.1

miRNA-mRNA interations detected through sequencing

MicroRNA targetome is known to use a seed sequence of 6–8 nt in their 50 end
(positions 2 to 7) to predominantly bind to either the 30 UTR or the coding sequence (CDS) of mRNAs [41] [8]. This binding approach is defined as canonical
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miRNA-binding site. However, it has been experimentally found that about
60% of miRNA binding activity is non-canonical, which involves other portions
of miRNA sequence outside the seed or with seed-like motifs including mismatches or bulges [8]. Therefore, to effectively capture miRNA target mRNA
interaction we use CLIP-seq data. CLIP-seq is a relatively new experimental technique to study the specificity of the binding activity for RNA-Binding
Proteins (RBP). This technique provides a comprehensive and genome-wide
map of the direct RNA binding sites for RBP. The application of CLIP-seq
to Ago2 has been used to identify the miRNA-binding sites. The datasets
are obtained from GEO under accession numbers SRP034075, these data contained two pancreatic cell lines (MIAPACA, HPNE) as reported in [10]. Raw
sequence data were downloaded using SRAtoolit, an efficient module to download high-volume data from NCBI. The preprocessing was carried out following
the workflow in Figure 3.1 above. To align the reads to a genome, Bowtie2 [30]
aligner, an ultrafast and memory-efficient tool for aligning sequencing reads
to long reference sequences was used along with human genemone hg19 to locate the reads locations in the genome. The output of this aligner is a SAM
(Sequence Alignment/Map) file. SAMtools [35] was used to convert SAM file
into its compressed binary version BAM (Binary Alignment/Mapping), Samtools is a set of powerful utilities for interacting with and post-processing short
DNA sequence read alignments in the SAM formats. An important step in this
miRNA-RNA data interaction preprocessing is the peak calling task. This is a
computational method used to identify areas in the genome that have been enriched with aligned reads as a result of performing ChIP-sequencing, CLIP-seq
experiments among many other. Pyicoclip from Pyicoteo [3] library, a suite of
tools for the analysis of high-throughput sequencing data, was used because it

16
Interaction List (SRX893318/SRX893321 data from GEO)
hTERT-HPNE CLIP cell line (Normal)
#miRNA:
20
#Genes:
350
Total Interaction #:
436
MIA PACA-2 CLIP cell line (Carcinoma)
#miRNA:
17
#Genes:
285
Total Interaction #:
414
Table 3.1: Cell line data summary
is suitably designed for CLIP-seq peaks. Pyicoclip was performed with p-value
of 0.001, value used in [8]. The output was formatted into BED6 format. To get
the reads count, featureCounts [37] from Subreads package was used. Reads
counts provide an overall summary of the coverage for the genomics features of
interest. In the output obtained from the previous steps, genomics coordinates
were available, these were used to perform miRNA annotations with the help
of intersect function from bedtools [42]. The annotation and miRNA sequence
files were retrieved from miRBase [18, 27] and liftover [28] was performed on
the annotatin file to match the assembly version in use (hg19). The resulting
files were fed in miRBShunter [8] pipeline to identify interactions from both
canonical and non-canonical binding site. This pipeline follows the de novo’s
approach for the identification of enriched motifs from Ago2 CLIP-seq peaks
and it computes the calculate the miRNA::RNA heteroduplex score for the
identified interactions. The output at this stage constitutes one input to our
pipeline. Table 3.1 provides a summary of the data.
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3.2

Gene expression data

The normal dataset (Normal solid tissues genes expression) for our study
was obtained from GEO ( https://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi) under GSE28735 [57], a study of microarray gene-expression profiles of
45 matching pairs of pancreatic tumor and adjacent non-tumor tissues. After a log transformation of the expressions, limma [43] was used to identify
differentially expressed genes.
TCGA PAAD cohort data, RNA-seq and miRNA-seq were downloaded using GDCRNATools [36], a package that enable the preprocessing of the data
and analysis of genes differential expression. For this cohort 183 samples were
downloaded for RNA-seq along with their miRNA-seq, common samples data
were extracted and to make up the tumor samples set 174 samples were kept
which involves 21 samples in stage 1, 146 samples in stage 2, 3 samples in stage
3 and 4 samples in stage 4. To complete the preprocessing, TMM [45] normalization, an essential step in an RNA-seq analysis, in which the read count
matrix is transformed to allow for meaningful comparison of counts across
samples, it is required in that the proportion of mRNA corresponding to a
given gene may change across biological conditions [14] and Voom [32] transformation needed to scale our data from raw counts onto a scale that accounts
for library size difference as libraries sequenced at a greater depth will result
in higher counts were performed. Processed data were fed into DEAnalysis
method of GDCRNATools for Differential expression analysis using edgeR [44]
method from Robinson. A list of 448 differentially expressed genes (number of
up and down reg) were retained to match common genes set in both normal
and tumor dataset. A cut off threshold of |log2 F old Change (F C)| > 1 and
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adjusted P − value < 0.05 were considered for differential gene identification.
The results of the preprocessing is summarized in table 3.2.
Normal Tissue (GSE28735 from GEO)
#Samples:
45
#Genes:
448
Tumor Tissue (PAAD from TCGA)
#Samples:
174
#Genes:
448
Stage 1:
21 Samples
Stage 2:
146 Samples
Stage 3:
3 Samples
Stage 4:
4 Samples
DE-miRNA (PAAD from TCGA)
#Samples
178
#miRNA: 26
(T+N):
Table 3.2: TCGA PAAD data summary
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Chapter 4

Methodologies

To reconstruct this network, a graphical lasso approach was used to recover
the structure of the network from the data.

4.1

Gene regulation network reconstruction

GRN is an abstraction to explain regulatory mechanisms behind gene expression. Our workflow is depicted in Figure 4.1. First, a Gaussian graphical

Figure 4.1: Worklow for gene-gene network construction
model (GGM) was explored to explain the dependency relationship between
genes, the variables in a continuous multivariate system. In order to learn the
underlying relationships embedded under complex GRN, we assume that our
data is sampled from the following multivariate Gaussian distribution:

p(x | µ, Σ) =

1
(2π)n/2 |Σ|1/2




1
> −1
exp − (x − µ) Σ (x − µ)
2

(4.1)

20
where µ is the mean vector and Σ is the covariance matrix. Σ is a square
positive definite matrix and Ω = Σ−1 is called precision matrix. We can
rewrite the formula in Equation 4.1 for µ = 0 and Ω as shown in Equation 4.2.
X
|Ω|1/2
1X
2
p (x1 , x2 , . . . , xn | µ = 0, Ω) =
exp
−
ω
(x
)
−
ωij xi xj
ii
i
(2π)n/2
2 i
i<j

!

(4.2)
Equation 4.2 can be considered as a continuous Markov Random Field (MRF)
with potentials defined on every node and edge where ωii (xi )2 is a node potential denoted as φ(xi ), and ωij xi xj is an edge potential denoted as φ(xi , xj ).
Given n × p data matrix X where n is the number samples, p is the number of
genes, and observations x1 , . . . , xn are independent and identically distributed
(i.i.d) and sampled from N (µ, Σ) where Σ is p×p positive definite matrix. Two
variables pi and pj are conditionally independent if and only if Ω[i, j] = 0 [31].
The problem for learning the conditional independence relationship between
the variables with the given data becomes now estimating the coefficients ωii
and ωij shown in Equation 4.2. The scaled log-likelihood of a sample x ∈ Rp
in a Gaussian graphical model with mean µ and precision matrix Ω is, up to
a constant given by:

L(Ω, x) ≡ log det(Ω) − (x − µ)> Ω(x − µ)

(4.3)

We define the average scaled log-likelihood of N samples x(1) , . . . , x(n) which
b by:
depends only on sample covariance matrix Σ
b ≡
L(Ω, Σ)


1 X
L Ω, x(n)
N n

b
= log det(Ω) − tr(ΣΩ)

(4.4)
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We impose some sparsity assumptions in our learning problem as sparse network are common in real-work applications. The reasons for such assumptions
are: (1) biological networks are often sparse [20]; (2) computations on dense
graphs require huge amount of resources; (3) dense graphs are difficult to interpret. Banerjee et al., [4] showed that finding the sparse precision matrix
which fits most to a dataset is an NP-hard problem. Additionally, p×p covariance matrix Σ requires O(p2 ) parameters for accurate estimation, however, we
often have n  p. Therefore, some form of regularization can be used to make
the computation tractable. Structured sparsity can be obtained by regularizing with `1 -norm. Our goal is to solve the following regularized maximum
likelihood problem by minimizing regularized minus log-likelihood:

b − log det(Ω) + λkΩk1
min L(Ω) := tr(ΣΩ)
Ω>0

(4.5)

Equation 4.5 is a convex optimization problem where regularization paramb
eter λ > 0, and linear term (tr(ΣΩ)),
the negative log determinant function
(log det(Ω)), the `1 penalty, and the set of all positive definite matrices are convex. The solution to the convex optimization problem in Equation 4.5 is known
as the graphical lasso [15]. Learning the structures using the observations in
different groups separately does not take into consideration the similarities between their structures. In fact, the structure of a graphical model on a single
sample group shouldn’t deviate much from the rest. Since differences between
the graphical models are of interest, Danaher et al., [12] proposed a technique
for jointly estimating multiple graphical models. They solved the following
optimization problem subject to constraint that Ω1 , . . . , Ω(K) are positive def-
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inite.
min L({Ω}) :=

{Ω>0}

K
X

b (k) Ω(k) ) − log det(Ω(k) ) + P ({Ω})
tr(Σ

(4.6)

k=1

where P ({Ω}) denotes a convex penalty function. They defined two regularization functions to foster the precision matrices to share certain characteristics. Their first proposed regularization function, fused graphical lasso as
shown in Equation 4.7, applies `1 regularization for sparsity constraint, and
the fused lasso [22] penalty regularization function to the differences between
corresponding elements of each pair of precision matrices to encourage similar
edge values.

P ({Ω}) = λ1

K X
X

(k)

|ωij | + λ2

k=1 i6=j

XX
k<k0

(k)

(k0 )

|ωij − ωij |

(4.7)

i,j

where λ1 and λ2 are nonnegative tuning parameters. Second regularization
function they proposed, group graphical lasso as shown in Equation 4.8, also
applies `1 regularization for sparsity constraint, and the group lasso penalty [55]
to the (i, j) element across all K precision matrices in order to have an identical
pattern of non-zero elements in the precision matrices.

P ({Ω}) = λ1

4.2

K X
X

v
uK
X uX
(k)2
(k)
t
ωij
|ωij | + λ2

k=1 i6=j

i6=j

(4.8)

k=1

miRNA-gene binding network inference

Next, we learned a BN to represent the binding relationship between miRNAs
and genes. Interactions among miRNA and genes were obtained as per the
steps described in section one of the Chapter 2. These interactions were derived
from two Pancreactic cell lines: a total of 436 interactions involving 20 unique
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miRNAs and 350 uniques genes for hTERT-HPNE and 414 interactions among
17 unique miRNAs and 285 unique genes. We used these interactions to build
the evidence matrix E, where E[i, j] = 1 if there is a reported interaction
between gene i and miRNA j. We first used the Greedy Hill Climbing (GHC)
method to find initial DAGs, and then applied the Tabu search algorithm
starting with those DAGs with tabu size 100 and a maximum of 2 changes
that decreases the score of model. The Bayesian Dirichlet equivalence uniform
(BDeu) [9] scoring implemented in aGrUM package [17] was used for this
score-based learning process. Figure 4.2 depicts the workflow of this stage.
Once we obtained a DAG for binding network, we converted the DAG to
its Markov equivalent undirected graphical model (moralized graph). In the
equivalent undirected model, there is an undirected edge between two nodes
if they share a directed edge in the original graph or they are parents of the
same node. In the pancreatic cancer case, the binding network in the DAG and
undirected graphical model have 1,278 and 5,484 edges, respectively. In order
to explain the impact of miRNA-mediated regulation in the gene interaction
networks, we used the entropic Gromov-Wasserstein distance [46] to assess
the similarity between two phenotypes by including only expressions of genes
involved in direct interactions of miRNAs as well as the interactions of their
dependencies. As shown in Figure 4.3, calculating the distance of normal and
cancer expression profiles to understand the impact of miRNA M1 involves
both the expressions of direct interaction with G1 and all interactions of its
dependencies G3. We only kept the distances if they are greater than the
threshold, 0.0127, which is the distance between the normal and cancer profiles
based on the entire DEGs. We then ranked the miRNA-mRNA interactions
based on the distance with the reasoning that existence of top-ranked binding
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cases differentiates the regulatory mechanisms in cancer compared to normal
more than other binding sites.

Figure 4.2: Worklow for miRNA-gene binding network inference

Figure 4.3: Illustration of connecting GRN and miRNA co-binding models

4.3

Functional analysis

We built networks for each progressive stage following the aforementioned
steps and then investigated the structural differences of the learned models.
Specifically, we focus on gene-gene or miRNA-gene interactions that are newly
introduced to each stage and absent in the preceding stage, which are defined
as stage-specific interactions. For instance, if there exists an interaction between gene A and gene B in stage 1, and interaction between gene B and gene
C in stage 2,then we only consider gene A for stage 1, and gene C for stage 2
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for functional analysis. We excluded the common gene B in these interactions
from set enrichment analysis because including such a common gene may undermine differences between pairing patterns specific to stages. Based on this
information, functional roles enriched in each stage was analyzed through the
following approaches. Genes were clustered based on their projection at a specific level of the gene ontology corpus. Enrichment test were computed using
clusterProfiler [52] for gene ontology terms and were followed by a KEGG [26]
Pathways analysis. This was performed to assess biological significance of the
gene sets obtained by testing over-representation of gene ontology terms.

4.4

Conditional interactions identified using supervised
neural network model

We explore a deep learning solution based on Convolutional Neural Network
(CNNs) [33] to elucidate the conditional miRNA-mRNA interaction based on
gene and miRNA expression profiles in this study. CNN is a special kind
of deep neural network, designed to be spatially invariant and to recognize
patterns directly from an input. It is composed of multiple building blocks
such as convolution layers, pooling layers, and fully connected layers. Early
layers of CNN models learn low-level features, while deep layers learn high-level
features which are composed of low-level features. We designed multiple layers
of two-input 1D CNN model to discover spatial gene and miRNA features. In
our CNN architecture, we add max pooling layers after convolution layers to
reduce spatial dimensions which also helps to control overfitting. Additionally,
we add dropout layers after dense layers to control overfitting. We truncate
the CNN architecture at concatenation layer and saved the weights in the last
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dense layers before concatenation layers after training is complete.
miRNA-gene binding interactions obtained from our De Novo preprocessing were considered to serve as a positive label for classifiers. One branch of an
architecture gets gene expression values, and the other branch gets miRNA expression values and they are concatenated down the line for performing binary
classification task to predict binding relationships from expression values.
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Chapter 5

Results and Discussion

We used AIC criterion for model selection, and we found `1 = 0.7 and `2 =
0.025 gives the best fitted model to our data. We investigated the structural
differences of the learned models for each cancer stage. The GRN models for
each cancer stage are learned together with normal samples. We hypothesized
that GRN model for different cancer stages should not deviate much from the
GRN for normal condition. Figure 5.1 shows the numbers of edges in each
subset and their intersections. The large number of common edges in the
intersection of all GRNs verifies our hypothesis.
To analyze the result of this network, we used Cytoscape [47] for visualization and analysis. In gene regulation networks, including miRNA–mRNA
interaction networks, one of the most relevant metrics is centrality. This is a
measure of the degree, i.e., the number of edges connected to a vertex; the assumption is that vertices with the highest degrees (with the most connections)
play important roles in the functioning of the system, making the degree of
centrality a useful guide for focusing attention on the system’s most crucial
elements [11, 1]. We consider the betweenness centrality measurement. Table
5.1 report some statistics about the Gene-Gene network. A visualization of
this network with Cytoscape is shown in Figure 5.2. The degree distribution
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Figure 5.1: Venn diagram for gene interactions on the identified networks
of each network inferred (stage-specific) fits the power law, which is a defining property of a scale-free network. This property gives the network a great
tolerance against errors. Figure 5.3 reports the plot of each network.

Number of Nodes
Number of Edges
Min Degree of a Node
Max Degree of a Node
Average Degree
Betweenness Centrality
Clustering Coefficient

Normal
247
3029
1
89
26
0.6
0.511

Stage 1
307
4187
1
97
28
1
0.455

Stage 2
263
3548
1
96
27
1
0.551

Stage 3
185
995
1
46
12
0.1
0.453

Stage 4
224
1559
1
62
14
0.1
0.465

Table 5.1: Results on the predicted gene-gene interactions
There are in total 100 new genes that appeared in the Stage 1 and not
present in the solid normal tissue of Pancreatic cancer while from Stage 1 to
Stage 2, 15 new genes make their appearance. From stage 2 to stage 3, 6 new
genes introduced in the network and 44 new genes from Stage 3 to Stage 4.
Once miRNA and genes are bound together, We consider the miRNAs with
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(a) Normal-All Stages

(b) Normal-Stage 1

Figure 5.2: Network visualization
(a) represent the intersection between all the stage and normal whereas
(b) shows the edges only present in Stage 1.
smaller degrees (less than 20) to be particularly important. This is because
when a miRNA with a high degree is excluded from the dataset, many potentially important dependents are also taken off from the analysis which leads to
a greater difference from the baseline. miRNAs with degrees in top-20 percent
are:hsa-miR-139-5p, hsa-miR-451a, hsa-miR-194-5p, hsa-miR-150-5p. Table
5.2 reports the mirna genes binding obtained. Four of which are experimentally validated microRNAs.
Using these 12 identified miRNA that have binding information to our
DEGs list. we assessed their functional analysis using KEGG [26] and GO
enrichment analysis. With the help of dotplot functionality of clusterProfile
package [53] in R, Figure 5.4 showed significant functions enriched in more
advanced stage (a) and detailed the genes associated with one or more terms
(b) during cancer progression.
Gene Set Enrichment Analysis (GSEA) [49] on gene sets from KEGG path-
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Figure 5.3: Degree distribution of network inferred for each stage
ways was performed and 74 enriched pathway were found and the resulting
table can be found in Appendix A1. Most of the resulting pathways are also
reported in [54].

In the absence of benchmarking data, a 10-fold cross-validation was performed to analyze the model’s performance. Our model has demonstrated
promising prediction power on identifying conditional miRNA-Gene interactions. It achieved an average accuracy of about 97% and Figure 5.5 plots the
receiver operating characteristic.
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miRNA
hsa-miR-139-5p
hsa-miR-139-3p
hsa-miR-451a
hsa-miR-194-5p
hsa-miR-192-5p
hsa-miR-196a-5p
hsa-miR-196b-5p
hsa-miR-210-3p
hsa-miR-135b-5p
hsa-miR-1224-5p
hsa-miR-375
hsa-miR-155-5p

Gene
ENSG00000186642
ENSG00000182253
ENSG00000188536
ENSG00000006611
ENSG00000170608
ENSG00000272763
ENSG00000123388
ENSG00000253293
ENSG00000106031
ENSG00000130821
ENSG00000281406
ENSG00000089199
ENSG00000167964
ENSG00000116299
ENSG00000234883

Table 5.2: miRNA-Gene Network Result
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(a) Enrichment analysis for GO Biological Process

(b) Top 5 significant terms GO Enrichment

Figure 5.4: Functional Analysis
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Figure 5.5: Performance evaluation based on ROC (Receiver Operating Characteristic)
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Chapter 6

Conclusions and Future work

This thesis presented an integrative methodology to construct multifaceted
gene regulatory networks among different types of bio-molecules in cancers.
Gene-gene and miRNA binding networks were inferred based on sequencingderived expression data and interaction information. The major contribution
of this study is the presentation of a network learner that can merge continuous
and discrete data models, and supports queries on variables of interest for
interaction predictions, which can be generalized for similar applications in
biomedical research.
Two important directions are identified and can be pursued in the future to
improve this work. First, a deep investigation of gene expression conversion
into image to unlock the full potential of a CNN-based model. An attempt to
use expression value directly into a 1-D vector has been made and this will be
pursued along with how to encode in a meaningful way expression value into
image for a CNN model interactions inference. Second, how to address data
augmentation within real biological data as limited samples size poses serious
challenges while inadequate data augmentation has serious repercussions.
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Appendix A

Appendix: Selected KEGG pathways
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ID
hsa05034
hsa04974
hsa04972
hsa00830
hsa04911
hsa01230
hsa05204
hsa00980
hsa00982
hsa04950
hsa05143
hsa05320
hsa05330
hsa04672
hsa05332
hsa05340
hsa04080
hsa03010
hsa05144
hsa04623
hsa05321
hsa04260
hsa05416
hsa05150
hsa04612
hsa00512
hsa05140
hsa00190
hsa04061
hsa04662
hsa04640
hsa04658
hsa05323
hsa04970

Description
Alcoholism
Protein digestion and absorption
Pancreatic secretion
Retinol metabolism
Insulin secretion
Biosynthesis of amino acids
Chemical carcinogenesis
Metabolism of xenobiotics by cytochrome P450
Drug metabolism - cytochrome P450
Maturity onset diabetes of the young
African trypanosomiasis
Autoimmune thyroid disease
Allograft rejection
Intestinal immune network for IgA production
Graft-versus-host disease
Primary immunodeficiency
Neuroactive ligand-receptor interaction
Ribosome
Malaria
Cytosolic DNA-sensing pathway
Inflammatory bowel disease
Cardiac muscle contraction
Viral myocarditis
Staphylococcus aureus infection
Antigen processing and presentation
Mucin type O-glycan biosynthesis
Leishmaniasis
Oxidative phosphorylation
Viral protein interaction with cytokine and cytokine receptor
B cell receptor signaling pathway
Hematopoietic cell lineage
Th1 and Th2 cell differentiation
Rheumatoid arthritis
Salivary secretion
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hsa04660
hsa04620
hsa04650
hsa05235
hsa05142
hsa04625
hsa04666
hsa04659
hsa04670
hsa04064
hsa04933
hsa05145
hsa04630
hsa04611
hsa00010
hsa04613
hsa04380
hsa05162
hsa04514
hsa05135
hsa00601
hsa04142
hsa04145
hsa04621
hsa05161
hsa05164
hsa05152
hsa04664
hsa04062
hsa05133
hsa05167
hsa04060
hsa05169
hsa05170
hsa05417
hsa05146
hsa05163
hsa04668
hsa04915
hsa05166

T cell receptor signaling pathway
Toll-like receptor signaling pathway
Natural killer cell mediated cytotoxicity
PD-L1 expression and PD-1 checkpoint pathway in cancer
Chagas disease
C-type lectin receptor signaling pathway
Fc gamma R-mediated phagocytosis
Th17 cell differentiation
Leukocyte transendothelial migration
NF-kappa B signaling pathway
AGE-RAGE signaling pathway in diabetic complications
Toxoplasmosis
JAK-STAT signaling pathway
Platelet activation
Glycolysis / Gluconeogenesis
Neutrophil extracellular trap formation
Osteoclast differentiation
Measles
Cell adhesion molecules
Yersinia infection
Glycosphingolipid biosynthesis - lacto and neolacto series
Lysosome
Phagosome
NOD-like receptor signaling pathway
Hepatitis B
Influenza A
Tuberculosis
Fc epsilon RI signaling pathway
Chemokine signaling pathway
Pertussis
Kaposi sarcoma-associated herpesvirus infection
Cytokine-cytokine receptor interaction
Epstein-Barr virus infection
Human immunodeficiency virus 1 infection
Lipid and atherosclerosis
Amoebiasis
Human cytomegalovirus infection
TNF signaling pathway
Estrogen signaling pathway
Human T-cell leukemia virus 1 infection
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